Substituted pyridines that are JNK inhibitors
US8278337B2 · kind B2 · utility
8Cited by
0References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 17, 2007 |
| Grant date | Oct 2, 2012 |
| Priority date | — |
| Expiry date | Jun 16, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compounds of the formula (I) wherein X is N or CH, and Y is N or CR5. Also disclosed are methods of treating JNK and ERK mediated diseases using the compounds of formula 1.0.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.